Ultra-LEAF™ Purified anti-human CD3 300473 from BioLegend

Product Specs
ItemUltra-LEAF™ Purified anti-human CD3
CompanyBioLegend
Price $2,354.00Supplier Page View Company Product Page
Catalog Number300473
Quantity50 mg
ApplicationsFC - Quality tested, CyTOF®, - Verified, IHC-F, IP, Activ, WB - Reported in the literature, not verified in house
Conjugate/TagUnconjugated, Ultra Low Endotoxin Azide Free
Format0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative
ReactivityHuman
TargetCD3
IsotypeMouse IgG1, kappa
CloneUCHT1
HostMouse
Antibody TypePrimary
NCBI Full Gene NameCD3 epsilon subunit of T-cell receptor complex
NCBI Gene AliasesCD3epsilon, IMD18, T3E, TCRE
ClonalityMonoclonal
ConcentrationThe antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL. Older lots may have also been bottled at 1 mg/mL. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

(1) Phenotypic signatures of immune selection in HIV-1 reservoir cellsNatureFebruary 1, 2023Sun W, Gao C, Hartana CA, Osborn MR, Einkauf KB, Lian X, Bone B, Bonheur N, Chun TW, Rosenberg ES, et al.

(2) SLAMF6 compartmentalization enhances T cell functionsLife science allianceFebruary 1, 2023Gartshteyn Y, Askanase AD, Song R, Bukhari S, Dragovich M, Adam K, Mor A.

(3) A RIPK3-independent role of MLKL in suppressing parthanatos promotes immune evasion in hepatocellular carcinomaCell discoveryJanuary 17, 2023Jiang X, Deng W, Tao S, Tang Z, Chen Y, Tian M, Wang T, Tao C, Li Y, Fang Y, et al.

(4) Human NK cells confer protection against HIV-1 infection in humanized miceThe Journal of clinical investigationDecember 15, 2022Sungur CM, Wang Q, Ozantürk AN, Gao H, Schmitz AJ, Cella M, Yokoyama WM, Shan L.

(6) A blood atlas of COVID-19 defines hallmarks of disease severity and specificityCellMarch 3, 2022COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk., COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium..

(7) ASK120067 potently suppresses B-cell or T-cell malignancies in vitro and in vivo by inhibiting BTK and ITKFrontiers in pharmacologyJanuary 1, 2022Song P, Bai G, Chan S, Zhang T, Tong L, Su Y, Shen Y, Chen Y, Liu Y, Lai M, et al.

(8) Tofacitinib-Induced Modulation of Intestinal Adaptive and Innate Immunity and Factors Driving Cellular and Systemic PharmacokineticsCellular and molecular gastroenterology and hepatologyJanuary 1, 2022Texler B, Zollner A, Reinstadler V, Reider SJ, Macheiner S, Jelusic B, Pfister A, Watschinger C, Przysiecki N, Tilg H, et al.

(9) PD-1-stimulated T cell subsets are transcriptionally and functionally distinctiScienceSeptember 24, 2021Lerrer S, Tocheva AS, Bukhari S, Adam K, Mor A.

(10) Very-low-carbohydrate diet enhances human T-cell immunity through immunometabolic reprogrammingEMBO molecular medicineAugust 9, 2021Hirschberger S, Strauß G, Effinger D, Marstaller X, Ferstl A, Müller MB, Wu T, Hübner M, Rahmel T, Mascolo H, et al.

(11) Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockadeJournal for immunotherapy of cancerJuly 1, 2021Jeong S, Park E, Kim HD, Sung E, Kim H, Jeon J, Kim Y, Jung UJ, Son YG, Hong Y, et al.

(13) CDK8 Fine-Tunes IL-6 Transcriptional Activities by Limiting STAT3 Resident Time at the Gene LociCell reportsDecember 22, 2020Martinez-Fabregas J, Wang L, Pohler E, Cozzani A, Wilmes S, Kazemian M, Mitra S, Moraga I.

(14) In Vitro Assays to Study PD-1 Biology in Human T CellsCurrent protocols in immunologySeptember 1, 2020Tocheva AS, Lerrer S, Mor A.

(16) TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector FunctionsCell reportsSeptember 17, 2019Leng T, Akther HD, Hackstein CP, Powell K, King T, Friedrich M, Christoforidou Z, McCuaig S, Neyazi M, Arancibia-Cárcamo CV, et al.

Ultra-LEAF™ Purified anti-human CD3 from BioLegend